Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma

Chin Med J (Engl). 2023 Oct 5;136(19):2362-2364. doi: 10.1097/CM9.0000000000002433.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / prevention & control
  • Hepatitis B virus
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / prevention & control
  • Tenofovir / therapeutic use
  • Treatment Outcome
  • Viral Load

Substances

  • Tenofovir
  • entecavir
  • Antiviral Agents